Cleared Traditional

K921937 - NOVA NUCLEUS CLINICAL CHEMICAL SYST

K921937 is the FDA 510(k) clearance for NOVA NUCLEUS CLINICAL CHEMICAL SYST by Nova Biomedical Corp.. It is a Class 2 Chemistry device (product code JGS) cleared through the Traditional 510(k) pathway after a 94-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
94d
Days
Class 2
Risk

K921937 is an FDA 510(k) clearance for the NOVA NUCLEUS CLINICAL CHEMICAL SYST, MODIFICATION. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on July 27, 1992 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corp. devices

Submission Details

510(k) Number K921937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 1992
Decision Date July 27, 1992
Days to Decision 94 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 88d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 99
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K921937.
NOVA 8 CRT ANALYZER
K924547 · Nova Biomedical Corp. · Jan 1993
KODAK EKTACHEM CLINICAL CHEMISTRY SLIDES (NAIL)
K924471 · Eastman Kodak Company · Nov 1992
ANALYZER: NOVA 10 CRT ANALYZER & QUALI CONT MATER
K923806 · Nova Biomedical Corp. · Sep 1992
OLYMPUS ISE MODULE
K921718 · Olympus Corp. · Jul 1992
NOVA 14 NA/K/CL/GLU/BUN ANALYZER
K922215 · Nova Biomedical Corp. · Jul 1992
NOVA 4 NA/K/C1/TCO2/LI ANALYZER
K915176 · Nova Biomedical Corp. · Jan 1992